In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative.

The in vitro susceptibilities of 1,310 clinical isolates to QA-241, a novel tricyclic quinolone, were evaluated in comparison with susceptibilities to norfloxacin, ofloxacin, enoxacin, and ciprofloxacin. The MICs of QA-241 for 90% of staphylococci, Enterococcus faecalis isolates, and streptococcal s...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Asahara, M, Tsuji, A, Goto, S, Masuda, K, Kiuchi, A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172615/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2679369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.8.1144
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!